Suchergebnisse - (Person:"De Meyer, Sandra")

PubPharm (10)

1

Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies

enthalten in: Journal of hepatology | 2015

von Lenz, O. | Verbinnen, T. | Fevery, B. | +8

2

Telaprevir twice daily is noninferior to telaprevir every 8 hours for patients with chronic hepatitis C

enthalten in: Gastroenterology | 2014

von Buti, M. | Agarwal, K. | Horsmans, Y. | +13

3

Evolution of treatment-emergent resistant variants in telaprevir phase 3 clinical trials

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2013

von Sullivan, J. | De Meyer, S. | Bartels, D. | +14

4

Sustained virologic response rates with telaprevir by response after 4 weeks of lead-in therapy in patients with prior treatment failure

enthalten in: Journal of hepatology | 2013

von Foster, G. | Zeuzem, S. | Andreone, P. | +12

CommentIn: J Hepatol. 2013 Jun;58(6):1259. - PMID 23376359

5

Virological analysis of once-daily and twice-daily darunavir/ritonavir in the ODIN trial of treatment-experienced patients

enthalten in: Antiviral therapy | 2013

von Lathouwers, E. | De La Rosa, G. | Van de Casteele, T. | +4

6

Characterization of telaprevir treatment outcomes and resistance in patients with prior treatment failure : results from the REALIZE trial

enthalten in: Hepatology (Baltimore, Md.) | 2012

von De Meyer, S. | Dierynck, I. | Ghys, A. | +8

7

Week 96 efficacy, virology and safety of darunavir/r versus lopinavir/r in treatment-experienced patients in TITAN

enthalten in: Current HIV research | 2012

von Bánhegyi, D. | Katlama, C. | da Cunha, C. | +7

8

Telaprevir for retreatment of HCV infection

enthalten in: The New England journal of medicine | 2011

von Zeuzem, S. | Andreone, P. | Pol, S. | +123

CommentIn: J Hepatol. 2011 Dec;55(6):1457-60. - PMID 21835142

9

Virological characterization of patients failing darunavir/ritonavir or lopinavir/ritonavir treatment in the ARTEMIS study : 96-week analysis

enthalten in: Antiviral therapy | 2011

von Lathouwers, E. | De Meyer, S. | Dierynck, I. | +4

10

In vitro susceptibility and virological outcome to darunavir and lopinavir are independent of HIV type-1 subtype in treatment-naive patients

enthalten in: Antiviral therapy | 2010

von Dierynck, I. | De Meyer, S. | Lathouwers, E. | +5

1
[1]